Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07054125 · ClinicalTrials.gov registry record

Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes

A clinical trial of Type 2 Diabetes Mellitus - Poor Control, sponsored by Whole Endo.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT07054125: Recruiting study of Type 2 Diabetes Mellitus - Poor Control, sponsored by Whole Endo.

NCT07054125 is a study of Type 2 Diabetes Mellitus - Poor Control that is actively recruiting participants, run by Whole Endo. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07054125, a study of Type 2 Diabetes Mellitus - Poor Control, is actively recruiting participants, sponsored by Whole Endo.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Interventions

  • BEHAVIORAL Education, lifestyle counseling, and peer support

Study Locations (1)

North Carolina

  • Whole Endo - Asheville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-08-01
Est. Completion 2028-08
Whole Endo

1 total trials

What NCT07054125 shows while recruiting

NCT07054125 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Type 2 Diabetes Mellitus - Poor Control appearing as the primary indexed condition, and to 1 intervention - of which Education, lifestyle counseling, and peer support is the first listed.

NCT07054125 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07054125 about?

NCT07054125 is a clinical study titled "Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes". This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM...

What is the current status of trial NCT07054125?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-08-01. Estimated completion is 2028-08.

What conditions does trial NCT07054125 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus - Poor Control.

What interventions are being tested in trial NCT07054125?

The interventions under investigation include: Education, lifestyle counseling, and peer support (BEHAVIORAL).

Who is sponsoring clinical trial NCT07054125?

This trial is sponsored by Whole Endo, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07054125 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus - Poor Control

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07054125, the US trial registry maintained by the National Library of Medicine. NCT07054125 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.